HEADER DE NOVO PROTEIN 11-JAN-16 5HI1 TITLE BACKBONE MODIFICATIONS IN THE PROTEIN GB1 HELIX: AIB24, BETA-3-LYS28, TITLE 2 BETA-3-LYS31, AIB35 COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN G-BINDING PROTEIN G; COMPND 3 CHAIN: A, B, C, D, E, F, G, H; COMPND 4 FRAGMENT: UNP RESIDUES 302-357; COMPND 5 SYNONYM: IGG-BINDING PROTEIN G; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: STREPTOCOCCUS SP. GROUP G; SOURCE 4 ORGANISM_TAXID: 1320 KEYWDS SYNTHETIC PROTEIN, DE NOVO PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.A.TAVENOR,Z.E.REINERT,G.A.LENGYEL,B.D.GRIFFITH,W.S.HORNE REVDAT 6 15-NOV-23 5HI1 1 ATOM REVDAT 5 27-SEP-23 5HI1 1 REMARK REVDAT 4 25-DEC-19 5HI1 1 REMARK REVDAT 3 13-SEP-17 5HI1 1 REMARK REVDAT 2 09-MAR-16 5HI1 1 JRNL REVDAT 1 24-FEB-16 5HI1 0 JRNL AUTH N.A.TAVENOR,Z.E.REINERT,G.A.LENGYEL,B.D.GRIFFITH,W.S.HORNE JRNL TITL COMPARISON OF DESIGN STRATEGIES FOR ALPHA-HELIX BACKBONE JRNL TITL 2 MODIFICATION IN A PROTEIN TERTIARY FOLD. JRNL REF CHEM.COMMUN.(CAMB.) V. 52 3789 2016 JRNL REFN ESSN 1364-548X JRNL PMID 26853882 JRNL DOI 10.1039/C6CC00273K REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.640 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 22864 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.750 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.1609 - 5.1786 0.99 1537 149 0.1983 0.2412 REMARK 3 2 5.1786 - 4.1116 1.00 1517 144 0.1682 0.1720 REMARK 3 3 4.1116 - 3.5923 1.00 1514 146 0.1795 0.2436 REMARK 3 4 3.5923 - 3.2640 1.00 1488 142 0.1987 0.2366 REMARK 3 5 3.2640 - 3.0301 1.00 1517 146 0.2149 0.2241 REMARK 3 6 3.0301 - 2.8515 1.00 1489 143 0.2198 0.2617 REMARK 3 7 2.8515 - 2.7087 1.00 1497 143 0.2407 0.2753 REMARK 3 8 2.7087 - 2.5908 1.00 1510 144 0.2438 0.2920 REMARK 3 9 2.5908 - 2.4911 1.00 1462 140 0.2545 0.2875 REMARK 3 10 2.4911 - 2.4051 1.00 1518 146 0.2428 0.3319 REMARK 3 11 2.4051 - 2.3299 1.00 1488 143 0.2543 0.3005 REMARK 3 12 2.3299 - 2.2634 1.00 1483 142 0.2623 0.3099 REMARK 3 13 2.2634 - 2.2038 0.97 1464 140 0.2706 0.2851 REMARK 3 14 2.2038 - 2.1500 0.92 1380 132 0.2688 0.3497 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.920 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3572 REMARK 3 ANGLE : 1.074 4886 REMARK 3 CHIRALITY : 0.066 562 REMARK 3 PLANARITY : 0.004 613 REMARK 3 DIHEDRAL : 20.209 1142 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HI1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000216969. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22880 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 41.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 11.40 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.04 REMARK 200 R MERGE FOR SHELL (I) : 0.23900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2QMT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1M SODIUM REMARK 280 ACETATE PH 4.5, 20% (W/V) PEG 4000, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 37.18550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 37.18550 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7, 8 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 217 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 228 LIES ON A SPECIAL POSITION. REMARK 375 HOH E 138 LIES ON A SPECIAL POSITION. REMARK 375 HOH F 132 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 15 CG CD OE1 OE2 REMARK 470 LYS B 4 CG CD CE NZ REMARK 470 LYS B 10 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP D 47 O HOH D 201 1.25 REMARK 500 NZ LYS D 10 O HOH D 202 1.90 REMARK 500 O THR B 11 O HOH B 101 1.92 REMARK 500 O HOH C 226 O HOH F 126 2.02 REMARK 500 OG1 THR D 44 OG1 THR D 53 2.06 REMARK 500 O THR B 11 O HOH B 102 2.10 REMARK 500 OD2 ASP D 47 O HOH D 203 2.13 REMARK 500 OH TYR C 33 OH TYR E 33 2.14 REMARK 500 O ASP H 47 O HOH H 101 2.15 REMARK 500 N LYS B 13 O HOH B 103 2.16 REMARK 500 N LEU G 12 O HOH G 101 2.17 REMARK 500 OD2 ASP C 1 O HOH C 201 2.17 REMARK 500 O GLU A 56 O HOH A 101 2.18 REMARK 500 OD2 ASP D 40 O HOH D 204 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH C 214 O HOH E 114 2756 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 B3K B 31 C GLN B 32 N 0.148 REMARK 500 GLN B 32 N GLN B 32 CA 0.181 REMARK 500 VAL C 29 N VAL C 29 CA 0.187 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 B3K C 28 CA - C - N ANGL. DEV. = -13.4 DEGREES REMARK 500 B3K G 31 CA - C - N ANGL. DEV. = 15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN C 8 76.71 -115.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 B3K A 28 VAL A 29 141.93 REMARK 500 B3K A 31 GLN A 32 143.17 REMARK 500 B3K B 28 VAL B 29 144.49 REMARK 500 B3K B 31 GLN B 32 139.80 REMARK 500 B3K C 31 GLN C 32 144.35 REMARK 500 B3K D 28 VAL D 29 144.24 REMARK 500 B3K D 31 GLN D 32 143.19 REMARK 500 B3K E 28 VAL E 29 145.53 REMARK 500 B3K E 31 GLN E 32 144.78 REMARK 500 B3K F 28 VAL F 29 142.75 REMARK 500 B3K F 31 GLN F 32 141.36 REMARK 500 B3K G 28 VAL G 29 143.83 REMARK 500 B3K G 31 GLN G 32 144.36 REMARK 500 B3K H 28 VAL H 29 142.79 REMARK 500 B3K H 31 GLN H 32 142.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 B3K A 28 -19.69 REMARK 500 B3K A 31 -17.03 REMARK 500 B3K B 28 -17.17 REMARK 500 B3K B 31 -17.88 REMARK 500 B3K C 28 -13.71 REMARK 500 B3K C 31 -18.21 REMARK 500 B3K D 28 -17.80 REMARK 500 B3K D 31 -18.72 REMARK 500 B3K E 28 -17.44 REMARK 500 B3K E 31 -17.02 REMARK 500 B3K F 28 -17.71 REMARK 500 B3K F 31 -18.95 REMARK 500 B3K G 28 -17.87 REMARK 500 B3K G 31 -18.81 REMARK 500 B3K H 28 -18.24 REMARK 500 B3K H 31 -18.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT D 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5HFY RELATED DB: PDB REMARK 900 RELATED ID: 5HG2 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 BACKBONE MODIFICATIONS IN THE PROTEIN GB1 HELIX: AIB24, BETA-3- REMARK 999 LYS28, BETA-3-LYS31, AIB35 DBREF 5HI1 A 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 B 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 C 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 D 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 E 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 F 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 G 1 56 UNP P19909 SPG2_STRSG 302 357 DBREF 5HI1 H 1 56 UNP P19909 SPG2_STRSG 302 357 SEQADV 5HI1 NH2 A 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 B 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 C 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 D 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 E 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 F 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 G 57 UNP P19909 AMIDATION SEQADV 5HI1 NH2 H 57 UNP P19909 AMIDATION SEQRES 1 A 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 A 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 A 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 A 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 A 57 THR VAL THR GLU NH2 SEQRES 1 B 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 B 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 B 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 B 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 B 57 THR VAL THR GLU NH2 SEQRES 1 C 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 C 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 C 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 C 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 C 57 THR VAL THR GLU NH2 SEQRES 1 D 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 D 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 D 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 D 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 D 57 THR VAL THR GLU NH2 SEQRES 1 E 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 E 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 E 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 E 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 E 57 THR VAL THR GLU NH2 SEQRES 1 F 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 F 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 F 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 F 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 F 57 THR VAL THR GLU NH2 SEQRES 1 G 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 G 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 G 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 G 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 G 57 THR VAL THR GLU NH2 SEQRES 1 H 57 ASP THR TYR LYS LEU ILE LEU ASN GLY LYS THR LEU LYS SEQRES 2 H 57 GLY GLU THR THR THR GLU ALA VAL ASP ALA AIB THR ALA SEQRES 3 H 57 GLU B3K VAL PHE B3K GLN TYR ALA AIB ASP ASN GLY VAL SEQRES 4 H 57 ASP GLY GLU TRP THR TYR ASP ASP ALA THR LYS THR PHE SEQRES 5 H 57 THR VAL THR GLU NH2 MODRES 5HI1 AIB A 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K A 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K A 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB B 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K B 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K B 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB C 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K C 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K C 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB D 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K D 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K D 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB E 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K E 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K E 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB F 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K F 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K F 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB G 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K G 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K G 31 LYS MODIFIED RESIDUE MODRES 5HI1 AIB H 24 ALA MODIFIED RESIDUE MODRES 5HI1 B3K H 28 LYS MODIFIED RESIDUE MODRES 5HI1 B3K H 31 LYS MODIFIED RESIDUE HET AIB A 24 6 HET B3K A 28 10 HET B3K A 31 10 HET AIB A 35 6 HET NH2 A 57 1 HET AIB B 24 6 HET B3K B 28 10 HET B3K B 31 10 HET AIB B 35 6 HET NH2 B 57 1 HET AIB C 24 6 HET B3K C 28 10 HET B3K C 31 10 HET AIB C 35 6 HET NH2 C 57 1 HET AIB D 24 6 HET B3K D 28 10 HET B3K D 31 10 HET AIB D 35 6 HET NH2 D 57 1 HET AIB E 24 6 HET B3K E 28 10 HET B3K E 31 10 HET AIB E 35 6 HET NH2 E 57 1 HET AIB F 24 6 HET B3K F 28 10 HET B3K F 31 10 HET AIB F 35 6 HET NH2 F 57 1 HET AIB G 24 6 HET B3K G 28 10 HET B3K G 31 10 HET AIB G 35 6 HET NH2 G 57 1 HET AIB H 24 6 HET B3K H 28 10 HET B3K H 31 10 HET AIB H 35 6 HET NH2 H 57 1 HET ACT C 101 4 HET ACT D 101 4 HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID HETNAM B3K (3S)-3,7-DIAMINOHEPTANOIC ACID HETNAM NH2 AMINO GROUP HETNAM ACT ACETATE ION FORMUL 1 AIB 16(C4 H9 N O2) FORMUL 1 B3K 16(C7 H16 N2 O2) FORMUL 1 NH2 8(H2 N) FORMUL 9 ACT 2(C2 H3 O2 1-) FORMUL 11 HOH *265(H2 O) HELIX 1 AA1 ASP A 22 ASN A 37 1 16 HELIX 2 AA2 ASP B 22 GLY B 38 1 17 HELIX 3 AA3 ASP C 22 ASN C 37 1 16 HELIX 4 AA4 ASP D 22 ASN D 37 1 16 HELIX 5 AA5 ASP E 22 ASN E 37 1 16 HELIX 6 AA6 ASP F 22 ASN F 37 1 16 HELIX 7 AA7 ASP G 22 ASN G 37 1 16 HELIX 8 AA8 ASP H 22 ASN H 37 1 16 SHEET 1 AA1 4 LYS A 13 GLU A 19 0 SHEET 2 AA1 4 THR A 2 ASN A 8 -1 N TYR A 3 O THR A 18 SHEET 3 AA1 4 THR A 51 THR A 55 1 O PHE A 52 N LYS A 4 SHEET 4 AA1 4 GLU A 42 ASP A 46 -1 N GLU A 42 O THR A 55 SHEET 1 AA2 4 GLY B 14 GLU B 19 0 SHEET 2 AA2 4 THR B 2 ASN B 8 -1 N LEU B 5 O THR B 16 SHEET 3 AA2 4 THR B 51 THR B 55 1 O PHE B 52 N LYS B 4 SHEET 4 AA2 4 GLU B 42 ASP B 46 -1 N GLU B 42 O THR B 55 SHEET 1 AA3 8 GLU C 42 ASP C 46 0 SHEET 2 AA3 8 THR C 51 THR C 55 -1 O THR C 53 N THR C 44 SHEET 3 AA3 8 THR C 2 ASN C 8 1 N LYS C 4 O PHE C 52 SHEET 4 AA3 8 LYS C 13 GLU C 19 -1 O THR C 16 N LEU C 5 SHEET 5 AA3 8 LYS E 13 GLU E 19 -1 O LYS E 13 N THR C 17 SHEET 6 AA3 8 THR E 2 ASN E 8 -1 N TYR E 3 O THR E 18 SHEET 7 AA3 8 THR E 51 THR E 55 1 O PHE E 52 N LYS E 4 SHEET 8 AA3 8 GLU E 42 ASP E 46 -1 N THR E 44 O THR E 53 SHEET 1 AA4 4 LYS D 13 GLU D 19 0 SHEET 2 AA4 4 THR D 2 ASN D 8 -1 N LEU D 5 O THR D 16 SHEET 3 AA4 4 THR D 51 THR D 55 1 O PHE D 52 N LYS D 4 SHEET 4 AA4 4 GLU D 42 ASP D 46 -1 N THR D 44 O THR D 53 SHEET 1 AA5 4 LYS F 13 GLU F 19 0 SHEET 2 AA5 4 THR F 2 ASN F 8 -1 N LEU F 5 O THR F 16 SHEET 3 AA5 4 THR F 51 THR F 55 1 O PHE F 52 N ILE F 6 SHEET 4 AA5 4 GLU F 42 ASP F 46 -1 N THR F 44 O THR F 53 SHEET 1 AA6 4 LYS G 13 GLU G 19 0 SHEET 2 AA6 4 THR G 2 ASN G 8 -1 N LEU G 5 O THR G 16 SHEET 3 AA6 4 THR G 51 THR G 55 1 O PHE G 52 N LYS G 4 SHEET 4 AA6 4 GLU G 42 ASP G 46 -1 N THR G 44 O THR G 53 SHEET 1 AA7 4 LYS H 13 GLU H 19 0 SHEET 2 AA7 4 THR H 2 ASN H 8 -1 N LEU H 7 O GLY H 14 SHEET 3 AA7 4 THR H 51 THR H 55 1 O PHE H 52 N ILE H 6 SHEET 4 AA7 4 GLU H 42 ASP H 46 -1 N THR H 44 O THR H 53 LINK C ALA A 23 N AIB A 24 1555 1555 1.33 LINK C AIB A 24 N THR A 25 1555 1555 1.33 LINK C GLU A 27 N B3K A 28 1555 1555 1.32 LINK C B3K A 28 N VAL A 29 1555 1555 1.35 LINK C PHE A 30 N B3K A 31 1555 1555 1.32 LINK C B3K A 31 N GLN A 32 1555 1555 1.34 LINK C ALA A 34 N AIB A 35 1555 1555 1.33 LINK C AIB A 35 N ASP A 36 1555 1555 1.33 LINK C GLU A 56 N NH2 A 57 1555 1555 1.33 LINK C ALA B 23 N AIB B 24 1555 1555 1.33 LINK C AIB B 24 N THR B 25 1555 1555 1.33 LINK C GLU B 27 N B3K B 28 1555 1555 1.33 LINK C B3K B 28 N VAL B 29 1555 1555 1.33 LINK C PHE B 30 N B3K B 31 1555 1555 1.32 LINK C B3K B 31 N GLN B 32 1555 1555 1.48 LINK C ALA B 34 N AIB B 35 1555 1555 1.33 LINK C AIB B 35 N ASP B 36 1555 1555 1.33 LINK C GLU B 56 N NH2 B 57 1555 1555 1.33 LINK C ALA C 23 N AIB C 24 1555 1555 1.33 LINK C AIB C 24 N THR C 25 1555 1555 1.33 LINK C GLU C 27 N B3K C 28 1555 1555 1.32 LINK C B3K C 28 N VAL C 29 1555 1555 1.47 LINK C PHE C 30 N B3K C 31 1555 1555 1.33 LINK C B3K C 31 N GLN C 32 1555 1555 1.23 LINK C ALA C 34 N AIB C 35 1555 1555 1.33 LINK C AIB C 35 N ASP C 36 1555 1555 1.33 LINK C GLU C 56 N NH2 C 57 1555 1555 1.33 LINK C ALA D 23 N AIB D 24 1555 1555 1.33 LINK C AIB D 24 N THR D 25 1555 1555 1.33 LINK C GLU D 27 N B3K D 28 1555 1555 1.33 LINK OE2 GLU D 27 NZ B3K D 31 1555 1555 1.30 LINK C B3K D 28 N VAL D 29 1555 1555 1.33 LINK C PHE D 30 N B3K D 31 1555 1555 1.33 LINK C B3K D 31 N GLN D 32 1555 1555 1.33 LINK C ALA D 34 N AIB D 35 1555 1555 1.33 LINK C AIB D 35 N ASP D 36 1555 1555 1.33 LINK C GLU D 56 N NH2 D 57 1555 1555 1.33 LINK C ALA E 23 N AIB E 24 1555 1555 1.33 LINK C AIB E 24 N THR E 25 1555 1555 1.33 LINK C GLU E 27 N B3K E 28 1555 1555 1.32 LINK C B3K E 28 N VAL E 29 1555 1555 1.33 LINK C PHE E 30 N B3K E 31 1555 1555 1.33 LINK C B3K E 31 N GLN E 32 1555 1555 1.30 LINK C ALA E 34 N AIB E 35 1555 1555 1.33 LINK C AIB E 35 N ASP E 36 1555 1555 1.33 LINK C GLU E 56 N NH2 E 57 1555 1555 1.33 LINK C ALA F 23 N AIB F 24 1555 1555 1.33 LINK C AIB F 24 N THR F 25 1555 1555 1.33 LINK C GLU F 27 N B3K F 28 1555 1555 1.33 LINK C B3K F 28 N VAL F 29 1555 1555 1.33 LINK C PHE F 30 N B3K F 31 1555 1555 1.32 LINK C B3K F 31 N GLN F 32 1555 1555 1.33 LINK C ALA F 34 N AIB F 35 1555 1555 1.33 LINK C AIB F 35 N ASP F 36 1555 1555 1.33 LINK C GLU F 56 N NH2 F 57 1555 1555 1.33 LINK C ALA G 23 N AIB G 24 1555 1555 1.33 LINK C AIB G 24 N THR G 25 1555 1555 1.33 LINK C GLU G 27 N B3K G 28 1555 1555 1.33 LINK C B3K G 28 N VAL G 29 1555 1555 1.33 LINK C PHE G 30 N B3K G 31 1555 1555 1.33 LINK C B3K G 31 N GLN G 32 1555 1555 1.33 LINK C ALA G 34 N AIB G 35 1555 1555 1.33 LINK C AIB G 35 N ASP G 36 1555 1555 1.33 LINK C GLU G 56 N NH2 G 57 1555 1555 1.33 LINK C ALA H 23 N AIB H 24 1555 1555 1.33 LINK C AIB H 24 N THR H 25 1555 1555 1.33 LINK C GLU H 27 N B3K H 28 1555 1555 1.33 LINK C B3K H 28 N VAL H 29 1555 1555 1.33 LINK C PHE H 30 N B3K H 31 1555 1555 1.33 LINK C B3K H 31 N GLN H 32 1555 1555 1.33 LINK C ALA H 34 N AIB H 35 1555 1555 1.33 LINK C AIB H 35 N ASP H 36 1555 1555 1.33 LINK C GLU H 56 N NH2 H 57 1555 1555 1.33 SITE 1 AC1 4 TYR C 3 ASP C 22 ASP C 47 LYS C 50 SITE 1 AC2 1 GLY F 14 CRYST1 74.371 73.430 79.436 90.00 99.35 90.00 C 1 2 1 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013446 0.000000 0.002215 0.00000 SCALE2 0.000000 0.013618 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012758 0.00000